Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v1-EN
Language English English
Date Updated 2017-04-04 2017-03-11
Drug Identification Number 02249324 02249324
Brand name APO-METHYLPHENIDATE APO-METHYLPHENIDATE
Common or Proper name METHYLPHENIDATE METHYLPHENIDATE
Company Name APOTEX INC APOTEX INC
Ingredients METHYLPHENIDATE HYDROCHLORIDE METHYLPHENIDATE HYDROCHLORIDE
Strength(s) 10MG 10MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 BTL 100 BTL
ATC code N06BA N06BA
ATC description PSYCHOSTIMULANTS AND NOOTROPICS PSYCHOSTIMULANTS AND NOOTROPICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-03-10 2017-03-10
Estimated end date 2017-04-04 2017-03-31
Actual end date 2017-04-03
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments APO-METHYLPHENIDATEHCLTAB USP 10MG500BTL is available APO-METHYLPHENIDATEHCLTAB USP 10MG500BTL is available
Health Canada comments